ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,803
Screening encounters
3,145
Diagnostic referrals
616
Outstanding pathways
250

Screening pathway

  1. Screening3,145Encounters
  2. Positive finding1,076Documented findings
  3. Referral616Diagnostic referrals
  4. Follow-up705Diagnostic visits
  5. Outcome366Resolved pathways

Stage totals use different units. Pending pathways: 250. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0179 · EXP-0179Synthetic · Site D

Full participant history through 2026-05-16, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-02-21

Referral-time risk

No matching referral was available at this observation date.

Screened participants

2803 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0645 · Expanded synthetic participant 0645Site A — Urban Referral Hub
EXP-0646 · Expanded synthetic participant 0646Site B — Peri-Urban Access Programme
EXP-0647 · Expanded synthetic participant 0647Site A — Urban Referral Hub
EXP-0648 · Expanded synthetic participant 0648Site C — Rural Outreach Programme
EXP-0649 · Expanded synthetic participant 0649Site A — Urban Referral Hub
EXP-0652 · Expanded synthetic participant 0652Site A — Urban Referral Hub
EXP-0654 · Expanded synthetic participant 0654Site D — Community Engagement Programme
EXP-0656 · Expanded synthetic participant 0656Site A — Urban Referral Hub
EXP-0657 · Expanded synthetic participant 0657Site D — Community Engagement Programme
EXP-0658 · Expanded synthetic participant 0658Site C — Rural Outreach Programme
EXP-0659 · Expanded synthetic participant 0659Site A — Urban Referral Hub
EXP-0660 · Expanded synthetic participant 0660Site B — Peri-Urban Access Programme
EXP-0661 · Expanded synthetic participant 0661Site C — Rural Outreach Programme
EXP-0664 · Expanded synthetic participant 0664Site A — Urban Referral Hub
EXP-0666 · Expanded synthetic participant 0666Site C — Rural Outreach Programme
EXP-0667 · Expanded synthetic participant 0667Site E — Resource-Constrained Navigation Programme
EXP-0668 · Expanded synthetic participant 0668Site D — Community Engagement Programme
EXP-0670 · Expanded synthetic participant 0670Site E — Resource-Constrained Navigation Programme
EXP-0671 · Expanded synthetic participant 0671Site B — Peri-Urban Access Programme
EXP-0672 · Expanded synthetic participant 0672Site D — Community Engagement Programme
EXP-0674 · Expanded synthetic participant 0674Site E — Resource-Constrained Navigation Programme
EXP-0676 · Expanded synthetic participant 0676Site C — Rural Outreach Programme
EXP-0677 · Expanded synthetic participant 0677Site B — Peri-Urban Access Programme
EXP-0682 · Expanded synthetic participant 0682Site D — Community Engagement Programme
EXP-0684 · Expanded synthetic participant 0684Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1281
HPV DNA
1401
Cytology
463

Navigation activity

Barrier documented
529
Contact attempt
906
Navigation intervention
224
Diagnostic booking
758
Diagnostic visit
705

Documented barriers

Contact difficulty
175
Transport difficulty
163
Appointment coordination
191

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.